DMK Pharmaceuticals Annual Stockholders’ Meeting Outcomes
PremiumCompany AnnouncementsDMK Pharmaceuticals Annual Stockholders’ Meeting Outcomes
7M ago
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
Premium
Press Releases
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
8M ago
DMK Pharmaceuticals regains full rights to commercialize ZIMHI
Premium
The Fly
DMK Pharmaceuticals regains full rights to commercialize ZIMHI
8M ago
DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
PremiumPress ReleasesDMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
10M ago
DMK Pharmaceuticals reports preclinical results on DPI-125
Premium
The Fly
DMK Pharmaceuticals reports preclinical results on DPI-125
10M ago
DMK Pharmaceuticals announces inducement option grant
Premium
The Fly
DMK Pharmaceuticals announces inducement option grant
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100